Avid Bioservices Inc reports results for the quarter ended in October - Earnings Summary

Avid Bioservices

06/12/2022 22:02

* Avid Bioservices Inc  CDMO.OQ  reported a quarterly
adjusted
loss of 2 cents​​ per share for the quarter ended in October.
The mean expectation of four analysts for the quarter was
for breakeven results per share.
    * Revenue rose 33.1% to $34.76 million from a year ago;
analysts
expected $32.05 million. 
    * Avid Bioservices Inc's reported EPS for the quarter was a
loss
of 2 cents​.
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Avid Bioservices Inc shares had fallen by 19.5% this
quarter and
lost 47.3% so far this year.
    * The company reported a quarterly loss of $1.16 million.
    * Wall Street's median 12-month price target for Avid
Bioservices
Inc is $26.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data December
6 at 10:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Oct. 31 2022      0.00           -0.02          Missed
 Jul. 31 2022      0.04           0.02           Missed
 Apr. 30 2022      0.01           0.01           Met
 Jan. 31 2022      0.04           0.04           Met